- Home
- SGBX vs ADTX Comparison
SGBX vs ADTX Comparison
Compare SGBX & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- ADTX
- Stock Information
- Founded
- SGBX 2007
- ADTX 2017
- Country
- SGBX United States
- ADTX United States
- Employees
- SGBX N/A
- ADTX N/A
- Industry
- SGBX RETAIL: Building Materials
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- ADTX Health Care
- Exchange
- SGBX Nasdaq
- ADTX Nasdaq
- Market Cap
- SGBX 2.7M
- ADTX 3.1M
- IPO Year
- SGBX 2017
- ADTX 2020
- Fundamental
- Price
- SGBX $0.65
- ADTX $1.39
- Analyst Decision
- SGBX
- ADTX
- Analyst Count
- SGBX 0
- ADTX 0
- Target Price
- SGBX N/A
- ADTX N/A
- AVG Volume (30 Days)
- SGBX 1.6M
- ADTX 1.2M
- Earning Date
- SGBX 06-13-2025
- ADTX 08-18-2025
- Dividend Yield
- SGBX N/A
- ADTX N/A
- EPS Growth
- SGBX N/A
- ADTX N/A
- EPS
- SGBX N/A
- ADTX N/A
- Revenue
- SGBX $4,574,857.00
- ADTX $55,323.00
- Revenue This Year
- SGBX $1,628.82
- ADTX $15,768.94
- Revenue Next Year
- SGBX N/A
- ADTX N/A
- P/E Ratio
- SGBX N/A
- ADTX N/A
- Revenue Growth
- SGBX N/A
- ADTX N/A
- 52 Week Low
- SGBX $0.30
- ADTX $1.28
- 52 Week High
- SGBX $3.75
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- SGBX 45.31
- ADTX 44.87
- Support Level
- SGBX $0.60
- ADTX $1.28
- Resistance Level
- SGBX $0.97
- ADTX $2.19
- Average True Range (ATR)
- SGBX 0.12
- ADTX 0.15
- MACD
- SGBX -0.03
- ADTX 0.08
- Stochastic Oscillator
- SGBX 19.90
- ADTX 30.77
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.